Alginate-hydrogel versus alginate-solid system. Efficacy in bone regeneration in osteoporosis.
Alginates
/ chemistry
Animals
Bone Morphogenetic Protein 2
/ administration & dosage
Bone Regeneration
/ drug effects
Cells, Cultured
Delayed-Action Preparations
Disease Models, Animal
Estradiol
/ administration & dosage
Female
Hydrogels
/ chemistry
Injections
Microspheres
Osteoporosis
/ drug therapy
Porifera
/ chemistry
Rats
Tissue Scaffolds
/ chemistry
BMP-2
Bone regeneration
Mesenchymal stem cells
Osteoporosis
Scaffold
β-Estradiol
Journal
Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
22
11
2019
revised:
01
04
2020
accepted:
21
04
2020
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
31
3
2021
Statut:
ppublish
Résumé
In the present study, two different PLGA-Alginate scaffolds, a hydrogel (HY) and a solid sponge (SS), were developed for β-estradiol and BMP-2 sustained delivery for bone regeneration in osteoporosis. β-Estradiol and BMP-2 were encapsulated in PLGA and PLGA-Alginate microspheres respectively. Scaffolds were characterized in vitro in terms of porosity, water uptake, release rate and HY rheological properties. BMP-2 release profiles were also analysed in vivo. The bone regeneration induced by both HY and SS was evaluated using a critical-sized bone defect in an osteoporotic (OP) rat model. Compared to HY, SS presented 30% higher porosity, more than double water absorption capacity and almost negligible mass loss compared to the 40% of HY. Both systems were flexible and fit well the defect shape, however, HY has the advantage of being injectable. Despite both delivery systems had similar composition and release profile, bone repair was around 30% higher with SS than with HY, possibly due to its longer residence time at the defect site. The incorporation of mesenchymal stem cells obtained from OP rats did not result in any improvement or synergistic effect on bone repair.
Identifiants
pubmed: 32600680
pii: S0928-4931(19)34237-7
doi: 10.1016/j.msec.2020.111009
pii:
doi:
Substances chimiques
Alginates
0
Bone Morphogenetic Protein 2
0
Delayed-Action Preparations
0
Hydrogels
0
Estradiol
4TI98Z838E
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111009Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interest.